Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study
- PMID: 19051043
- PMCID: PMC2720089
- DOI: 10.1007/s10552-008-9273-z
Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study
Abstract
Obesity and insulin resistance have been implicated in the etiology of pancreatic cancer (PC). Whether adiponectin and/or leptin, two adipocyte-secreted hormones important in metabolic regulation, are associated with PC pathogenesis and whether adiponectin receptors are expressed in PC remains unknown. In a hospital-based case-control study, we studied 81 cases with incident, histologically confirmed PC and 81 controls matched on gender and age between 2000 and 2007 to investigate the role of adiponectin and leptin adjusting for risk factors linked to PC. In a separate study, we also studied for the first time whether adiponectin receptors 1 and 2 are expressed in PC by studying 16 PC tumor tissue samples which were analyzed using immunohistochemistry. When subjects were divided into control-defined quartiles of adiponectin and leptin, lower leptin but higher adiponectin levels were associated with PC (p = 0.001 and p = 0.05 respectively) before and after controlling for age, gender, BMI, smoking status, alcohol consumption, history of diabetes, and family history of pancreatic cancer. Of the PC tumor tissue samples analyzed, 87.5% had positive or strong positive expression of AdipoR1 and 93.7% had positive or strong positive expression of AdipoR2. Further prospective studies are needed to determine whether the elevated adiponectin and low leptin levels reported in this study reflect compensatory changes during PC progression and thus can be used as markers for PC or whether they are causally implicated in PC.
Similar articles
-
Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies.Oncology. 2007;73(3-4):261-9. doi: 10.1159/000127424. Epub 2008 Apr 17. Oncology. 2007. PMID: 18424891
-
Adiponectin-Resistance in Obesity.Adv Exp Med Biol. 2017;960:415-441. doi: 10.1007/978-3-319-48382-5_18. Adv Exp Med Biol. 2017. PMID: 28585210 Review.
-
Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.Endocr Relat Cancer. 2009 Dec;16(4):1197-210. doi: 10.1677/ERC-09-0043. Epub 2009 Aug 6. Endocr Relat Cancer. 2009. PMID: 19661131
-
Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.Metabolism. 2013 Dec;62(12):1830-9. doi: 10.1016/j.metabol.2013.09.007. Epub 2013 Oct 17. Metabolism. 2013. PMID: 24140093
-
Adiponectin receptors in energy homeostasis and obesity pathogenesis.Prog Mol Biol Transl Sci. 2013;114:317-42. doi: 10.1016/B978-0-12-386933-3.00009-1. Prog Mol Biol Transl Sci. 2013. PMID: 23317789 Review.
Cited by
-
Paracrine and endocrine effects of adipose tissue on cancer development and progression.Endocr Rev. 2011 Aug;32(4):550-70. doi: 10.1210/er.2010-0030. Epub 2011 Jun 2. Endocr Rev. 2011. PMID: 21642230 Free PMC article. Review.
-
Association of variants on ADIPOQ and AdipoR1 and the prognosis of gastric cancer patients after gastrectomy treatment.Mol Biol Rep. 2015 Feb;42(2):355-61. doi: 10.1007/s11033-014-3775-4. Epub 2014 Oct 1. Mol Biol Rep. 2015. PMID: 25270251
-
Adiponectin receptor 2 is negatively associated with lymph node metastasis of colorectal cancer.Oncol Lett. 2012 Apr 1;3(4):756-760. doi: 10.3892/ol.2012.583. Epub 2012 Feb 7. Oncol Lett. 2012. PMID: 22740988 Free PMC article.
-
Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms.Mol Carcinog. 2012 Jan;51(1):53-63. doi: 10.1002/mc.20778. Mol Carcinog. 2012. PMID: 22162231 Free PMC article. Review.
-
Molecular pathways: adiponectin and leptin signaling in cancer.Clin Cancer Res. 2013 Apr 15;19(8):1926-32. doi: 10.1158/1078-0432.CCR-12-0930. Epub 2013 Jan 25. Clin Cancer Res. 2013. PMID: 23355630 Free PMC article. Review.
References
-
- Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin. 2004;54:8–29. - PubMed
-
- Warshaw AL, Fernandez-del CC. Pancreatic carcinoma. N Engl J Med. 1992;13(326):455–465. - PubMed
-
- Schima W, Ba-Ssalamah A, Kolblinger C, Kulinna-Cosentini C, Puespoek A, Gotzinger P. Pancreatic adenocarcinoma. Eur Radiol. 2007;17:638–649. - PubMed
-
- Freelove R, Walling AD. Pancreatic cancer: diagnosis and management. Am Fam Physician. 2006;73:485–492. - PubMed
-
- Fuchs CS, Colditz GA, Stampfer MJ, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med. 1996;156:2255–2260. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous